000 | 01047 a2200301 4500 | ||
---|---|---|---|
005 | 20250515173336.0 | ||
264 | 0 | _c20090612 | |
008 | 200906s 0 0 eng d | ||
022 | _a1533-4406 | ||
024 | 7 |
_a10.1056/NEJMc090579 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aGarcia, David A | |
245 | 0 | 0 |
_aWarfarin pharmacogenetics. _h[electronic resource] |
260 |
_bThe New England journal of medicine _cJun 2009 |
||
300 |
_a2474; author reply 2475 p. _bdigital |
||
500 | _aPublication Type: Comment; Letter | ||
650 | 0 | 4 | _aAlgorithms |
650 | 0 | 4 |
_aAnticoagulants _xadministration & dosage |
650 | 0 | 4 | _aContinuity of Patient Care |
650 | 0 | 4 | _aGenotype |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aInternational Normalized Ratio |
650 | 0 | 4 | _aPharmacogenetics |
650 | 0 | 4 |
_aWarfarin _xadministration & dosage |
700 | 1 | _aHylek, Elaine | |
773 | 0 |
_tThe New England journal of medicine _gvol. 360 _gno. 23 _gp. 2474; author reply 2475 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1056/NEJMc090579 _zAvailable from publisher's website |
999 |
_c18918591 _d18918591 |